Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam HCl in Primary Hypercholesterolemia
CTR20233461Phase 3Completed
- Sponsor
- Jingxin Pharmaceutical
- Start
- Oct 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of colesevelam in hypercholesterolemia, sponsored by Jingxin Pharmaceutical. Started Oct 2023; status: completed.
02
Drugs
colesevelam
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20233461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233461.